Clinical Trials Directory

Trials / Completed

CompletedNCT06304298

NLR and PLR Levels Following IPACK Block in Knee Arthroplasty

The Neutrophil-to-lymphocyte Ratio (NLR) and Platelet-to-lymphocyte Ratio (PLR) Levels Following IPACK Block in Knee Arthroplasty: a Randomized, Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Effect of iPACK block on NLR and PLR following knee arthroplasty

Detailed description

The NLR is a sensitive indicator of inflammation confirmed in numerous studies and has a predictive and prognostic value. NLR is a cheap, simple, fast-acting, readily available stress and inflammation parameter with high sensitivity and low specificity. Dynamic changes in the NLR precede the clinical state for several hours and may alert clinicians early about the ongoing pathological process. NLR is a new promising marker of cellular immune activation, an important indicator of stress and systemic inflammation. It opens a new dimension for clinical medicine to understand better the biology of inflammation, the linkage, and antagonism between innate and adaptive immunity, and its clinical consequences for health and disease. NLR is affected not only by surgical trauma but also by the method of anesthesia. In recent years, the influence of regional anesthesiology on reducing the inflammatory response after surgical procedures has been emphasized. However, there have been very few studies evaluating the effect of various methods of anesthesia on the NLR. This is the first study to investigate the effect of regional anesthesia on the NLR and PLR in patients undergoing knee replacement surgery.

Conditions

Interventions

TypeNameDescription
DRUG0.9% Sodium Chloride InjectionAfter spinal anesthesia, the ultrasound-guided iPACK block will be performed with 20ml of 0.9% sodium chloride
DRUGRopivacaine 0.2% Injectable SolutionAfter spinal anesthesia, the ultrasound-guided iPACK block will be performed with 20ml of 0.2% ropivacine

Timeline

Start date
2024-03-30
Primary completion
2025-01-16
Completion
2025-02-10
First posted
2024-03-12
Last updated
2025-03-24

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06304298. Inclusion in this directory is not an endorsement.